BGX
BGX
More

state-of-the-art antibody technologies

state-of-the-art antibody technologiesstate-of-the-art antibody technologiesstate-of-the-art antibody technologies

Craft an original in advanced diagnosis, effective prophylaxis, and therapy

Contact Us

About Us

Why Our Team

 We are visionary in designing innovative product-market fit through a combined deep understanding and integration of science and ingenuity. 

Experience the Difference

 We craft an original, innovative product via our custom design workflow to make our vision come to life. 

Our Success

   

Our team successfully developed potent broadly human anti-SARS-CoV-2 antibodies from elite responders. The developed antibodies were licensed to Hibiocy Co. Ltd, which further developed into a nasal spray medical device named VAILL COVITRAP™. The Thai FDA has approved VAILL COVITRAP™ as a Class 4 medical device, making Thailand the first country to approve the manufacturing of human monoclonal antibody-based COVID-19 nasal spray.

Contact Us

Email us at info@biogenexis.com 

Biogenexis

Hours

Monday - Friday: 8:00am - 5:00pm

Saturday - Sunday: Closed

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Copyright © 2022 Biogenexis - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept